| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 2 securities · may seek to influence control | ||||||
|
Tevogen Inc.
13D/A
TVGN · 88165K200
|
91.1% |
11/4/2026
Event 11/2/2026
|
||||
|
Tevogen Bio Holdings Inc.
13D/A
TVGN · 88165K101
|
59.7% |
7/14/2026
Event 7/10/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.